MedTrace Logo

A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy Subjects

NCT04696952 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2025-02-28

No results posted yet for this study

Summary

A clinical study to evaluate the residual effects of TS-142 on driving performance in healthy and elderly subjects.

Conditions

  • Healthy Subjects

Interventions

DRUG

TS-142

TS-142

DRUG

Zopiclone

Zopiclone

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Taisho Pharmaceutical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Taisho Director · Taisho Pharmaceutical Co., Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-16
Primary Completion
2022-01-05
Completion
2022-01-05

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04696952 on ClinicalTrials.gov